Vaccine · BLA
Flucelvax NDC 85766-263
Influenza a virus a/tasmania/318/2025 cvr-351 (H1n1) antigen (Mdck cell derived, Propiolactone inactivated) 15 ug/.5mL + 2 more ingredients · Injection, Suspension · Intramuscular · Sportpharm LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 85766-263-10 | 85766026310 | 10 SYRINGE, GLASS in 1 CARTON (85766-263-10) / .5 mL in 1 SYRINGE, GLASS (85766-263-01)Marketed from Jul 1, 2026 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Flucelvax
- Generic name (nonproprietary)
- influenza a virus a/tasmania/318/2025 cvr-351 (h1n1) antigen (mdck cell derived, propiolactone inactivated), influenza a virus a/tasmania/787/2025 cvr-388 (h3n2) antigen (mdck cell derived, propiolactone inactivated), influenza b virus b/arizona/21/2025 antigen (mdck cell derived, propiolactone inactivated)
- Active ingredients
- Influenza a virus a/tasmania/318/2025 cvr-351 (H1n1) antigen (Mdck cell derived, Propiolactone inactivated) — 15 ug/.5mLInfluenza a virus a/tasmania/787/2025 cvr-388 (H3n2) antigen (Mdck cell derived, Propiolactone inactivated) — 15 ug/.5mLInfluenza b virus - b/arizona/21/2025 antigen (Mdck cell derived, Propiolactone inactivated) — 15 ug/.5mL
- Dosage form
- Injection, Suspension
- Route
- Intramuscular
- Labeler
- Sportpharm LLC
- Product type
- Vaccine
- Marketing category
- BLA — Biologics License ApplicationApplication BLA 125408
- Marketing start
- Marketing end
- Identifiers
- Product ID 85766-263_5a564edc-8375-1611-e063-6294a90a0b80SPL ID 5a564edc-8375-1611-e063-6294a90a0b80
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Immunization administration (CPT 90460–90474)
Giving a vaccine is reported separately from the vaccine product code, with an immunization administration code. Which code applies depends on the patient's age, the route and whether counselling was provided.
- NDC on a medical claim
N485766026310followed by a unit qualifier and the quantityPackage 85766-0263-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
The FDA listing for this product does not reference a label (SPL) set.
Other NDCs under BLA 125408
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Flucelvaxinfluenza a virus a/tasmania/318/2025 cvr-351 (h1n1) antigen (mdck cell derived, propiolactone inactivated), influenza a virus a/tasmania/787/2025 cvr-388 (h3n2) antigen (mdck cell derived, propiolactone inactivated), influenza b virus b/arizona/21/2025 antigen (mdck cell derived, propiolactone inactivated) | Influenza a virus a/tasmania/318/2025 cvr-351 (H1n1) antigen (Mdck cell derived, Propiolactone inactivated) 15 ug/.5mL + 2 more ingredients | Injection, SuspensionIntramuscular | ASCLEMED USA INC. | 87063-299 |
| Flucelvaxinfluenza a virus a/tasmania/318/2025 cvr-351 (h1n1) antigen (mdck cell derived, propiolactone inactivated), influenza a virus a/tasmania/787/2025 cvr-388 (h3n2) antigen (mdck cell derived, propiolactone inactivated), influenza b virus b/arizona/21/2025 antigen (mdck cell derived, propiolactone inactivated) | Influenza a virus a/tasmania/318/2025 cvr-351 (H1n1) antigen (Mdck cell derived, Propiolactone inactivated) 15 ug/.5mL + 2 more ingredients | Injection, SuspensionIntramuscular | Seqirus Inc. | 70461-656 |
| Flucelvaxinfluenza a virus a/georgia/12/2022 cvr-167 (h1n1) antigen (mdck cell derived, propiolactone inactivated), influenza a virus a/victoria/800/2024 cvr-289 (h3n2) antigen (mdck cell derived, propiolactone inactivated), influenza b virus b/singapore/wuh4618/2021 antigen (mdck cell derived, propiolactone inactivated) | Influenza a virus a/georgia/12/2022 cvr-167 (H1n1) antigen (Mdck cell derived, Propiolactone inactivated) 15 ug/.5mL + 2 more ingredients | Injection, SuspensionIntramuscular | Bamboo US BidCo LLC | 83703-088 |